1-2 of 2
Harshini Sriram
Close
Sort by
Journal Articles

Circulating Clonal Plasma Cells at Diagnosis and Peripheral Blood Measurable Residual Disease Assessment Provide Powerful Prognostication Biomarkers in Newly-Diagnosed Multiple Myeloma Patients Treated without Autologous Transplant

Prashant Ramesh Tembhare, Harshini Sriram, Twinkle Khanka, Sanghamitra Gawai, Sitaram Ghogale, Nilesh Deshpande, Bhausaheb Bagal, Gaurav Chatterjee, Syed Khizer Hasan, Sweta Rajpal, Nikhil Patkar, Hasmukh Jain, Dhanlaxmi Lalit Shetty, Kinjalka Ghosh, Nitin Inamdar, Sachin Punatar, Anant Gokarn, Manju Sengar, Navin Khattry, Papagudi Ganesan Subramanian, Sumeet Gujral
Journal: Blood
Blood (2022) 140 (Supplement 1): 1135–1136.
https://doi.org/10.1182/blood-2022-165715
Published: 2022
Journal Articles

Serum microRNA Signature Predicting Poor Therapeutic Response to Bortezomib-Based Therapy and Clinical Outcome in Newly Diagnosed Multiple Myeloma: A Result of miRNA Profiling By Deep Sequencing

Harshini Sriram, Twinkle Khanka, Sanghamitra Gawai, Sitaram Ghogale, Nilesh Deshpande, Shipra Sharma, Sanchi Shah, Anirvan Chatterjee, Gaurav Chatterjee, Sweta Rajpal, Nikhil Patkar, Syed Khizer Hasan, Bhausaheb Bagal, Hasmukh Jain, Dhanlaxmi Lalit Shetty, Nitin Inamdar, Sachin Punatar, Anant Gokarn, Manju Sengar, Navin Khattry, Papagudi Ganesan Subramanian, Sumeet Gujral, Prashant R. Tembhare
Journal: Blood
Blood (2022) 140 (Supplement 1): 4292–4293.
https://doi.org/10.1182/blood-2022-168598
Published: 2022